Production & Manufacturing

The rapid expansion of the gene therapy sector has created a critical challenge in the production of viral vectors, the specialized vehicles used to deliver genetic material to target cells. As more therapies move from early-phase clinical trials toward...

The logistical and technical complexity of producing personalized medicines has reached a point where traditional batch testing methods are no longer sufficient to meet the needs of a growing patient population. In conventional pharmaceutical production, a product is manufactured...

A new research project from the Johns Hopkins Bloomberg School of Public Health has identified a pharmaceutical industry practice that could be a significant factor in global health disparities. Published in PLOS Global Public Health on July 07, 2026,...

Shilpa Biologicals Ltd, a subsidiary of Shilpa Medicare Ltd, has officially commissioned an advanced integrated Antibody–Drug Conjugate (ADC) GMP manufacturing site in Dharwad. Announced on 25 June 2026, the facility was specifically engineered to satisfy the rigorous global regulatory...

CPHI Milan 2026, recognized as a premier global gathering for the pharmaceutical industry, has announced the introduction of four new specialist zones for pharma at its upcoming event. Scheduled for October 6-8, 2026, at the Fiera Milan exhibition centre...

We are currently standing at the threshold of a medical revolution, transitioning from a model of managing chronic conditions to one of potentially curing genetic diseases at their foundational level. The promise of advanced therapeutics such as CRISPR-based gene...

Continuous manufacturing drug formulation represents the most significant leap in pharmaceutical engineering in over a century, fundamentally altering how medications are conceived, developed, and delivered to the global market. For decades, the industry operated under the batch manufacturing paradigm,...